Dr. Nucera Discusses the Role of RNA in Thyroid Cancer

Carmelo Nucera, MD, PhD
Published: Friday, Oct 31, 2014



Carmelo Nucera, MD, PhD, endocrinologist, assistant professor, Harvard Medical School, Division of Experimental Pathology, Beth Israel Deaconesss Medical Center, Boston, discusses the role of RNA in thyroid cancer.

Nucera says in the past year, it was discovered that less than 2% of the human genome is encoded for protein. This means that the noncoding region transcribes the majority of the genome.

As a new field, physicians are investigating the role of RNA in thyroid cancer. Nucera says he is attempting to discover the regulatory effect of noncoding RNA in thyroid cancer. There is also suspicion that BRAFV600E interplays with the RNA.

<<< View more from the 2014 ATA Annual Meeting



Carmelo Nucera, MD, PhD, endocrinologist, assistant professor, Harvard Medical School, Division of Experimental Pathology, Beth Israel Deaconesss Medical Center, Boston, discusses the role of RNA in thyroid cancer.

Nucera says in the past year, it was discovered that less than 2% of the human genome is encoded for protein. This means that the noncoding region transcribes the majority of the genome.

As a new field, physicians are investigating the role of RNA in thyroid cancer. Nucera says he is attempting to discover the regulatory effect of noncoding RNA in thyroid cancer. There is also suspicion that BRAFV600E interplays with the RNA.

<<< View more from the 2014 ATA Annual Meeting


View Conference Coverage
Online CME Activities
TitleExpiration DateCME Credits
34th Annual Miami Breast Cancer Conference® Clinical Case Vignette Series™May 25, 20182.0
Community Practice Connections™: CDK4/6 Inhibitors With the Experts: The Role of Emerging Agents for the Management of Metastatic Breast CancerMay 30, 20182.0
Publication Bottom Border
Border Publication
x